Key Points
- CEO Jitendra Mohan sold $11.76M worth of stock (94,971 shares) on Feb. 17 at $123.81, trimming his holding by 6.14% to 1,452,739 shares valued at about $179.9M.
- Multiple other senior officers also sold on the same day (COO sold ~94,971 shares ≈$11.76M; CFO sold 12,001 shares ≈$1.49M; GC sold 4,849 shares ≈$600k), which could amplify investor concern about insider liquidity-taking.
- Fundamentals remain strong: the company beat Q-quarter estimates with $0.58 EPS and revenue of $270.6M (up 91.8% YoY), and analysts remain largely bullish with an average price target around $192.89.
Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) General Counsel Philip Mazzara sold 4,849 shares of the business's stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $123.80, for a total transaction of $600,306.20. Following the sale, the general counsel owned 138,084 shares of the company's stock, valued at approximately $17,094,799.20. The trade was a 3.39% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Astera Labs Stock Performance
Shares of Astera Labs stock traded up $1.07 during trading hours on Friday, reaching $133.69. The company's stock had a trading volume of 1,295,397 shares, compared to its average volume of 5,618,000. Astera Labs, Inc. has a one year low of $47.13 and a one year high of $262.90. The company's 50 day simple moving average is $160.78 and its 200 day simple moving average is $174.12. The stock has a market cap of $22.58 billion, a P/E ratio of 109.58, a price-to-earnings-growth ratio of 2.55 and a beta of 1.50.
Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. The firm had revenue of $270.58 million for the quarter, compared to analysts' expectations of $249.46 million. During the same quarter last year, the company posted $0.37 earnings per share. Astera Labs's revenue was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, sell-side analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Astera Labs
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Assetmark Inc. raised its stake in shares of Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company's stock worth $25,000 after buying an additional 101 shares in the last quarter. Smartleaf Asset Management LLC boosted its stake in Astera Labs by 422.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company's stock valued at $32,000 after buying an additional 152 shares in the last quarter. Hilltop National Bank grew its holdings in Astera Labs by 100.0% during the fourth quarter. Hilltop National Bank now owns 200 shares of the company's stock worth $33,000 after acquiring an additional 100 shares during the period. Aventura Private Wealth LLC bought a new stake in Astera Labs in the fourth quarter worth about $33,000. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA acquired a new stake in Astera Labs in the 4th quarter valued at about $33,000. 60.47% of the stock is owned by institutional investors.
Key Astera Labs News
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Analyst note: Zacks highlights rising AI connectivity demand and Astera’s expansion of its NVLink and Scorpio product lines, framing a multiyear market opportunity that management is targeting (potential upside to revenue growth). ALAB Rides on Strong Connectivity Demand
- Positive Sentiment: Fundamentals & liquidity: A Seeking Alpha piece notes revenue more than doubled YoY, very strong free cash flow margins (above 30%), and a cash position of roughly $1.19B with zero debt — giving Astera financial flexibility to invest or weather headwinds. The Great Astera Labs Reset
- Neutral Sentiment: Short-interest data is effectively immaterial/odd (reported as zero shares and a 0.0 days ratio), so there’s no clear short-pressure signal to explain intraday moves. This looks like a non-factor for current trading dynamics. Short Interest Report
- Negative Sentiment: CEO sale: CEO Jitendra Mohan sold 94,971 shares at ~$123.81 (≈$11.76M), trimming his holding by ~6.14% — a large, pre-scheduled or open-market sale that can be viewed negatively by the market when combined with other insider activity. CEO Form 4
- Negative Sentiment: COO sale: COO Sanjay Gajendra sold 94,971 shares at ~$123.81 (≈$11.76M), reducing his position by ~5.84% — another large insider disposition on the same date that amplifies investor concern. COO Form 4
- Negative Sentiment: CFO sale: CFO Michael Truett Tate sold 12,001 shares at ~$123.81 (≈$1.49M), cutting his stake by ~5.88% — another senior officer sale the same day. CFO Form 4
- Negative Sentiment: General Counsel sale: GC Philip Mazzara sold 4,849 shares at ~$123.80 (≈$600k), a smaller but concurrent insider reduction. Multiple senior officers selling on the same day increases perceived signal of near‑term liquidity taking or diversification by insiders. GC Form 4
Analyst Upgrades and Downgrades
Several equities research analysts have weighed in on the company. Morgan Stanley reaffirmed an "overweight" rating and issued a $210.00 target price on shares of Astera Labs in a research report on Wednesday, December 3rd. Jefferies Financial Group reiterated a "buy" rating on shares of Astera Labs in a research report on Wednesday, December 3rd. Weiss Ratings restated a "hold (c-)" rating on shares of Astera Labs in a research report on Wednesday, January 21st. Raymond James Financial began coverage on Astera Labs in a report on Friday, November 21st. They set a "hold" rating on the stock. Finally, Roth Mkm increased their price objective on Astera Labs from $200.00 to $225.00 and gave the stock a "buy" rating in a report on Wednesday, November 5th. Fourteen investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $192.89.
View Our Latest Research Report on Astera Labs
Astera Labs Company Profile
(
Get Free Report)
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
